Aneurysm-Osteoarthritis Syndrome
Details of the Concept
Aneurysm-Osteoarthritis Syndrome (AOS) is an autosomal dominant connective tissue disorder caused by heterozygous inactivating mutations in SMAD3. Despite SMAD3 loss-of-function, aortic tissue paradoxically shows upregulated TGFβ signalling — the same paradox seen in Loeys-Dietz Syndrome (TGFBR1/2 LOF) and syndromic TAA (TGFB2 LOF). AOS is grouped with MFS-related conditions because shared dysregulated TGFβ signalling is believed to represent a common pathogenic mechanism for aortic disease across this group of heritable aortopathies.
Key Facts
- Genetic cause: Heterozygous inactivating mutations in SMAD3 (intracellular TGFβ pathway mediator) sources/marfan-cv-clingene-2015 (high)
- Cardinal features: Aortic aneurysms + arterial tortuosity + early-onset osteoarthritis + craniofacial features similar to Loeys-Dietz Syndrome sources/marfan-cv-clingene-2015 (high)
- Paradoxical TGFβ signalling: Immunohistochemistry of aortic tissue shows medial degeneration and fibrosis with paradoxically increased TGFβ signalling despite SMAD3 LOF — same pattern as LDS sources/marfan-cv-clingene-2015 (high)
- Three unrelated families initially described: van de Laar IM et al. Nat Genet 2011;43:121–126 (first description); phenotypic spectrum subsequently expanded (van de Laar 2012 J Med Genet) sources/marfan-cv-clingene-2015 (high)
- Distinguishing feature from LDS: Early-onset osteoarthritis is characteristic of AOS and not seen in LDS or MFS sources/marfan-cv-clingene-2015 (high)
- Mechanism of paradox: LOF mutations decreasing TGFβ activity during embryogenesis may promote secondary compensatory events leading to upregulation of TGFβ signalling postnatally; not fully resolved sources/marfan-cv-clingene-2015 (high)
Contradictions / Open Questions
- Paradox of LOF causing gain-of-function signalling: How inactivating SMAD3 mutations lead to increased TGFβ signalling is not mechanistically explained; compensatory upregulation is hypothesised but not proven
- Mouse model validation pending: As of publication (2015), characterisation of mouse models of AOS (alongside LDS and sTAA models) was expected to test the validity of the embryogenic compensatory hypothesis
- Shared with LDS/sTAA: Whether the same paradox mechanism applies to TGFBR1/2 (LDS) and TGFB2 (sTAA) LOF mutations remains unresolved
Connections
- Related to entities/Loeys-Dietz-Syndrome — highly similar craniofacial and aortic phenotype; both paradoxically upregulate TGFβ despite LOF mutations
- Related to concepts/Marfan-Syndrome — grouped as MFS-related disease; shared TGFβ pathway dysregulation
- Related to entities/FBN1 — MFS caused by FBN1 mutations; AOS grouped in same disease family via TGFβ pathway